Amgen (AMGN) patent on blockbuster Repatha drug invalid, judge rules - Bloomberg (REGN)

August 28, 2019 3:05 PM
Amgen (NASDAQ: AMGN) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Litigation Trader Talk